BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

781 related articles for article (PubMed ID: 35690959)

  • 1. Mendelian randomization analysis for attention deficit/hyperactivity disorder: studying a broad range of exposures and outcomes.
    Soler Artigas M; Sánchez-Mora C; Rovira P; Vilar-Ribó L; Ramos-Quiroga JA; Ribasés M
    Int J Epidemiol; 2023 Apr; 52(2):386-402. PubMed ID: 35690959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact and causal directions for the associations between diagnosis of ADHD, socioeconomic status, and intelligence by use of a bi-directional two-sample Mendelian randomization design.
    Michaëlsson M; Yuan S; Melhus H; Baron JA; Byberg L; Larsson SC; Michaëlsson K
    BMC Med; 2022 Apr; 20(1):106. PubMed ID: 35399077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Attention Deficit/Hyperactivity Disorder on Physical Health Outcomes: A 2-Sample Mendelian Randomization Study.
    Leppert B; Riglin L; Wootton RE; Dardani C; Thapar A; Staley JR; Tilling K; Davey Smith G; Thapar A; Stergiakouli E
    Am J Epidemiol; 2021 Jun; 190(6):1047-1055. PubMed ID: 33324987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing causality in the association between attention-deficit/hyperactivity disorder and obesity: a Mendelian randomization study.
    Martins-Silva T; Vaz JDS; Hutz MH; Salatino-Oliveira A; Genro JP; Hartwig FP; Moreira-Maia CR; Rohde LA; Borges MC; Tovo-Rodrigues L
    Int J Obes (Lond); 2019 Dec; 43(12):2500-2508. PubMed ID: 31000774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric disorders and Type 2 diabetes mellitus: A bidirectional Mendelian randomization.
    Tao H; Fan S; Zhu T; You L; Zheng D; Yan L; Ren M
    Eur J Clin Invest; 2023 Mar; 53(3):e13893. PubMed ID: 36259254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are there causal relationships between attention-deficit/hyperactivity disorder and body mass index? Evidence from multiple genetically informed designs.
    Liu CY; Schoeler T; Davies NM; Peyre H; Lim KX; Barker ED; Llewellyn C; Dudbridge F; Pingault JB
    Int J Epidemiol; 2021 May; 50(2):496-509. PubMed ID: 33221865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between ADHD and risk of six psychiatric disorders: a Mendelian randomization study.
    Guo Y; Li J; Hu R; Luo H; Zhang Z; Tan J; Luo Q
    BMC Psychiatry; 2024 Feb; 24(1):99. PubMed ID: 38317064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index and childhood symptoms of depression, anxiety, and attention-deficit hyperactivity disorder: A within-family Mendelian randomization study.
    Hughes AM; Sanderson E; Morris T; Ayorech Z; Tesli M; Ask H; Reichborn-Kjennerud T; Andreassen OA; Magnus P; Helgeland Ø; Johansson S; Njølstad P; Davey Smith G; Havdahl A; Howe LD; Davies NM
    Elife; 2022 Dec; 11():. PubMed ID: 36537070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating causality between liability to ADHD and substance use, and liability to substance use and ADHD risk, using Mendelian randomization.
    Treur JL; Demontis D; Smith GD; Sallis H; Richardson TG; Wiers RW; Børglum AD; Verweij KJH; Munafò MR
    Addict Biol; 2021 Jan; 26(1):e12849. PubMed ID: 31733098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention-Deficit/Hyperactivity Disorder and Major Depressive Disorder: Evidence From Multiple Genetically Informed Designs.
    Garcia-Argibay M; Brikell I; Thapar A; Lichtenstein P; Lundström S; Demontis D; Larsson H
    Biol Psychiatry; 2024 Mar; 95(5):444-452. PubMed ID: 37562520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship of Attention-Deficit/Hyperactivity Disorder With Posttraumatic Stress Disorder: A Two-Sample Mendelian Randomization and Population-Based Sibling Comparison Study.
    Wendt FR; Garcia-Argibay M; Cabrera-Mendoza B; Valdimarsdóttir UA; Gelernter J; Stein MB; Nivard MG; Maihofer AX; ; Nievergelt CM; Larsson H; Mattheisen M; Polimanti R; Meier SM
    Biol Psychiatry; 2023 Feb; 93(4):362-369. PubMed ID: 36335070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic support of a causal relationship between cannabis use and educational attainment: a two-sample Mendelian randomization study of European ancestry.
    Chen D; Wang X; Huang T; Jia J
    Addiction; 2023 Apr; 118(4):698-710. PubMed ID: 36465060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating causal relationships between genetically determined increased risk of attention-deficit/hyperactivity disorder (ADHD) and atopic dermatitis (AD): A Mendelian randomization analysis.
    Ng W; Loh M; Yew YW
    Exp Dermatol; 2023 Sep; 32(9):1468-1475. PubMed ID: 37317926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mendelian randomization study on causal effects of 25(OH)vitamin D levels on attention deficit/hyperactivity disorder.
    Libuda L; Naaresh R; Ludwig C; Laabs BH; Antel J; Föcker M; Hebebrand J; Hinney A; Peters T
    Eur J Nutr; 2021 Aug; 60(5):2581-2591. PubMed ID: 33245439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADHD and depression: investigating a causal explanation.
    Riglin L; Leppert B; Dardani C; Thapar AK; Rice F; O'Donovan MC; Davey Smith G; Stergiakouli E; Tilling K; Thapar A
    Psychol Med; 2021 Aug; 51(11):1890-1897. PubMed ID: 32249726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causal relationships between atopic dermatitis and psychiatric disorders: a bidirectional two-sample Mendelian randomization study.
    Cao S; Zhang Z; Liu L; Li Y; Li W; Li Y; Wu D
    BMC Psychiatry; 2024 Jan; 24(1):16. PubMed ID: 38172785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the causal relationships of attention-deficit/hyperactivity disorder with mental disorders and suicide attempt: a network Mendelian randomisation study.
    Meisinger C; Freuer D
    BMJ Ment Health; 2023 Jul; 26(1):. PubMed ID: 37669871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention-deficit/hyperactivity disorder and ischemic stroke: A Mendelian randomization study.
    Du R; Zhou Y; You C; Liu K; King DA; Liang ZS; Ranson JM; Llewellyn DJ; Huang J; Zhang Z
    Int J Stroke; 2023 Mar; 18(3):346-353. PubMed ID: 35670701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan.
    Vilar-Ribó L; Cabana-Domínguez J; Martorell L; Ramos-Quiroga JA; Sanchez-Roige S; Palmer AA; Vilella E; Ribasés M; Muntané G; Soler Artigas M
    Neuropsychopharmacology; 2023 Jun; 48(7):981-990. PubMed ID: 36906694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of causality between ADHD and Parkinson's disease: Mendelian randomization study.
    Li GH; Ge GM; Cheung CL; Ip P; Coghill D; Wong IC
    Eur Neuropsychopharmacol; 2020 Aug; 37():49-63. PubMed ID: 32565043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.